levonorgestrel has been researched along with Herpes Simplex Virus Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baeten, JM; Beesham, I; Beksinka, M; Bukusi, E; Deese, J; Donnell, D; Edward, V; Heffron, R; Kourtis, AP; Morrison, C; Mugo, NR; Philip, NM; Rees, H; Scoville, CW; Stalter, RM | 1 |
| Chappell, CA; Dezzutti, CS; Hillier, SL; Isaacs, CE; Meyn, LA; Moncla, BJ; Uranker, K; Xu, W | 1 |
1 trial(s) available for levonorgestrel and Herpes Simplex Virus Infection
| Article | Year |
|---|---|
Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial.
Topics: Contraception; Contraceptive Agents, Female; Female; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Male; Medroxyprogesterone Acetate | 2022 |
1 other study(ies) available for levonorgestrel and Herpes Simplex Virus Infection
| Article | Year |
|---|---|
The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
Topics: Adult; Cervix Uteri; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Immunity, Innate; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Postmenopause; Premenopause; Vagina; Vaginal Douching; Viral Plaque Assay; Young Adult | 2015 |